- Home
- TNGX vs OKE Comparison
TNGX vs OKE Comparison
Compare TNGX & OKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- OKE
- Stock Information
- Founded
- TNGX 2014
- OKE 1906
- Country
- TNGX United States
- OKE United States
- Employees
- TNGX N/A
- OKE N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- OKE Oil & Gas Production
- Sector
- TNGX Health Care
- OKE Utilities
- Exchange
- TNGX Nasdaq
- OKE Nasdaq
- Market Cap
- TNGX 735.0M
- OKE N/A
- IPO Year
- TNGX N/A
- OKE N/A
- Fundamental
- Price
- TNGX $6.64
- OKE $97.29
- Analyst Decision
- TNGX Strong Buy
- OKE Buy
- Analyst Count
- TNGX 8
- OKE 16
- Target Price
- TNGX $15.14
- OKE $93.60
- AVG Volume (30 Days)
- TNGX 885.7K
- OKE 2.4M
- Earning Date
- TNGX 11-06-2024
- OKE 10-29-2024
- Dividend Yield
- TNGX N/A
- OKE 4.07%
- EPS Growth
- TNGX N/A
- OKE N/A
- EPS
- TNGX N/A
- OKE 4.62
- Revenue
- TNGX $42,509,000.00
- OKE $19,099,000,000.00
- Revenue This Year
- TNGX $18.15
- OKE $26.50
- Revenue Next Year
- TNGX N/A
- OKE $11.02
- P/E Ratio
- TNGX N/A
- OKE $21.05
- Revenue Growth
- TNGX 26.16
- OKE N/A
- 52 Week Low
- TNGX $6.33
- OKE $63.33
- 52 Week High
- TNGX $13.01
- OKE $98.43
- Technical
- Relative Strength Index (RSI)
- TNGX 37.15
- OKE 60.50
- Support Level
- TNGX $6.83
- OKE $94.53
- Resistance Level
- TNGX $7.47
- OKE $98.43
- Average True Range (ATR)
- TNGX 0.37
- OKE 1.48
- MACD
- TNGX 0.11
- OKE 0.05
- Stochastic Oscillator
- TNGX 27.31
- OKE 72.50
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.